Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.3600 (-10.24%) ($7.3600 - $8.1600) on Mon. Apr. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.44% (three month average) | RSI | 37 | Latest Price | $7.3600(-10.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -2.3% a day on average for past five trading days. | Weekly Trend | ANPC declines -2.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) PCY(10%) IPO(9%) LIT(9%) XLB(9%) FXI(7%) | Factors Impacting ANPC price | ANPC will decline at least -2.72% in a week (0% probabilities). SHY(-13%) XLU(-5%) XBI(-5%) XLP(-4%) TBT(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.72% (StdDev 5.44%) | Hourly BBV | 0 () | Intraday Trend | -8% | | | |
|
Resistance Level | $8 | 5 Day Moving Average | $7.95(-7.42%) | 10 Day Moving Average | $8.03(-8.34%) | 20 Day Moving Average | $8(-8%) | To recent high | -34.6% | To recent low | 4.1% | Market Cap | $63m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |